Linezolid for drug-susceptible tuberculosis. (2019)

First Author: Ahmed S

Attributed to: Tuberculosis Treatment Trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(19)30110-0

PubMed Identifier: 30938294

Publication URI: http://europepmc.org/abstract/MED/30938294

Type: Journal Article/Review

Volume: 19

Parent Publication: The Lancet. Infectious diseases

Issue: 4

ISSN: 1473-3099